Comprehensive Study Guide on Solid Dosage Forms and Pharmaceutical Manufacturing

Fundamentals of Solid Dosage Forms and Tablet Characteristics

  • Solid dosage forms are formulated to contain a precise and exact amount of the drug itself. There is no such concept as an approximate amount of dosing for these preparations.
  • Precision in dosing is critical for patient safety and therapeutic efficacy.
  • Tablets often feature physical markers for identification and dosing accuracy:
    • Scoring: A mark in the middle of the tablet allowing it to be split.
    • Imprints: Identification numbers or letters indicating the dosage or manufacturer.
  • Tablets are generally designed to be easy to swallow, though some formulations may be larger or specifically designed to resist compression until reached by the target environment.
  • The formulation process must ensure that the bioavailability of the drug is not negatively altered.
  • An ideal tablet must be free of defects, including:
    • Chips
    • Cracks
    • Serration
    • Contamination
  • Friability: This is defined as a tablet's tendency to crumble or break during handling or transportation.
  • Friability Test: This test measures a tablet's resistance to mechanical stress and production processes without experiencing significant mass loss.
  • Drug release must occur in a predictable and usable manner to ensure effective absorption and onset of action.
  • The typical peak of absorption should occur within approximately 30 minutes30\,\text{minutes} for standard immediate-release formulations. Following the peak, the drug enters the elimination phase.

Pharmaceutical Ingredients: Actives and Excipients

  • Active Ingredients: These are the medicinal components responsible for the therapeutic effect.
  • Excipients: These are non-active ingredients that serve specific functions in the formulation. Common excipients include:
    • Diluents: Materials used to add bulk to a tablet (e.g., Lactose anhydrous, Calcium phosphate, Mannitol, Cellulose family).
    • Disintegrants: Starch is a common example, used to aid the tablet in breaking apart in the gastrointestinal tract.
    • Lubricants: Added during granulation or before compression to prevent the material from sticking to the machinery.

Tablet Manufacturing Methodologies

Direct Compression
  • This process involves mixing dry active ingredients and excipients together to create a blend used for immediate compression.
  • It does not involve the creation of granules.
  • The workflow involves milling for size reduction, followed by mixing, and finally direct compression where the powder is pressed into a mold and ejected.
  • This is a very fast manufacturing process.
Dry Granulation (The Slugging Method)
  • In this method, a "slug" is formed and then ground to a uniform size before being compressed into finished tablets.
  • Equipment used often includes a V blender, which can be extremely large (spanning the height of two floors).
  • A screen is utilized during the process to ensure the granules achieve the correct size.
  • After the initial slugging and screening, the material is blended again, potentially with a lubricant, before final compression.
Wet Granulation
  • This method involves the use of liquids to assist in the granulation process.
  • It is more time-consuming and involves more manipulation than dry methods.
  • It is not suitable for drugs that are:
    • Thermolabile (Thermal): Sensitive to heat, as the granules must be dried in an oven.
    • Hydrolyzable: Sensitive to water or moisture, which is introduced during the wet mixing phase.
  • Process steps include:
    1. Mixing the drug and diluent.
    2. Adding a liquid solution to create a mass.
    3. Passing the mass through a screen to size the granules.
    4. Drying the granules in an oven.
    5. Re-screening to ensure uniformity.
    6. Final compression.
  • Granulation improves the compressibility of tablets and ensures a more even distribution of the active ingredient.

Tablet Compression Equipment and Mechanical Problems

  • Single Punch Tablet Press: A laboratory-scale machine consisting of two main parts:
    • Bottom Piece: Contains a cavity or mold.
    • Top Piece (Small Rod): Punches down into the mold to compress the drug/excipient mixture into a tablet.
  • Commercial tablet presses may have limited flexibility regarding size and shape compared to compounding facilities, but they can produce thousands of tablets in a short timeframe.
  • Tablet Processing Problems:
    • Capping/Delamination: Separation of the tablet, often caused by air entrapment during compression.
    • Lamination: The separation of the tablet into two or more distinct layers.
    • Picking: The removal of surface material from the tablet during manufacture.

Modified Release and Specialized Coating

  • Enteric Coating: This coating allows a tablet to resist the acidic pH of the stomach and instead release the drug in the intestine. Cellulose-based materials are common for this purpose.
  • Multiple Layer Tablets: Formed through multiple compression steps, these tablets can combine several drugs or different release profiles within a single unit.
  • Controlled vs. Sustained Release:
    • Controlled Release: The drug is released at a constant, predetermined rate over a set period.
    • Sustained Release: These provide an initial "burst" of release followed by a slow, gradual release over time.

Pharmacokinetic Analysis of Release Profiles

  • Key Parameters on a Concentration-Time Graph:
    • Y-axis: Blood sample concentration (CC\text{max}).
    • X-axis: Time (TT\text{max}).
    • Maximum Safe Level: The threshold above which the drug concentration becomes unstable or toxic.
    • Minimum Effective Concentration (MEC): The line below which the drug is sub-therapeutic and provides no effect.
    • Onset of Action: The time it takes for the drug to reach the MEC. Ordinary tablets have a fast onset (<1 hour<1\,\text{hour}). Sustained-release tablets have a delayed onset.
    • Duration of Action: The total time the drug concentration remains above the MEC. Sustained-release forms provide a significantly longer duration of action compared to ordinary tablets.

Drug Degradation and Stability

  • Primary Chemical Degradation Processes:
    1. Hydrolysis: The most common process responsible for drug degradation.
    2. Oxidation.
    3. Photolysis.
    4. Trace Metals.
  • Environmental Factors:
    • UV Light: Identified as the most destructive/degradable visible wave for drug stability.
  • Accelerated Stability Testing: This involves placing a drug in an environment where conditions (heat, humidity) are exaggerated to accelerate degradation. This data is used to extrapolate the drug's shelf life and stability profile.

Comminution: Particle Size Reduction

  • Comminution is the process of reducing the particle size of a solid material.
  • There are three primary processes of comminition:
    1. Trituration: Grinding a powder in a mortar and pestle.
    2. Levigation: Reducing particle size with the help of a small amount of liquid (a levigating agent).
    3. Milling: Mechanical size reduction used in large-scale production.

Questions & Discussion

  • Question: Which environmental factor is most responsible for drug degradation?
  • Response: UV light is the most destructive.
  • Question: Which chemical process is most frequently responsible for drug degradation?
  • Response: Hydrolysis.
  • Question: What is the purpose of accelerated stability testing?
  • Response: We are accelerating the conditions of the environment to accelerate drug degradation in order to extrapolate the stability problems of the drug.
  • Question: What are the three processes of comminition?
  • Response: Trituration, levigation, and milling.